✦ LIBER ✦

Baroreceptor control of central and regional hemodynamics with isoflurane in the dog

✍ Scribed by R. J. Bagshaw; R. H. Cox

Book ID: 115103332
Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 948 KB
Volume: 32
Category: Article
ISSN: 0001-5172
DOI: 10.1111/j.1399-6576.1988.tb02693.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regional Lung Function and Central Hemod

Regional Lung Function and Central Hemodynamics Following Normovolemic Hemodilution in the Dog

✍ B. Rosberg 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

Regional and systemic hemodynamics durin

Regional and systemic hemodynamics during hemodilution with isovolemic hydroxyethyl starch solution alone and in combination with sodium nitroprusside- or isoflurane-induced controlled hypotension in isoflurane-anesthetized dogs

✍ Masao Kobori; Hideru Negishi; Hiroe Nagai; Kyoko Iyama 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 537 KB

Baroreceptor Control of Systemic Haemody

Baroreceptor Control of Systemic Haemodynamics at Incremental Halothane Levels in the Dog

✍ R. J. Bagshaw; R. H. Cox 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Comparison of the effects of isoflurane

Comparison of the effects of isoflurane and halothane on left ventricular global and regional functions in the chronically instrumented dog with normal coronaries

✍ A. Khalil; J. Chamberlain; F. Mitchell; P. Swan 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Central and Splanchnic Haemodynamics in

Central and Splanchnic Haemodynamics in the Dog During Controlled Hypotension with Sodium Nitroprusside

✍ M. Lagerkranser; M. Andreen; L. Irestedt 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Controlling the acute hemodynamic effect

Controlling the acute hemodynamic effects associated with IV administration of particulate drug dispersions in dogs

✍ Lawrence de Garavilla; Nancy Peltier; Elaine Merisko-Liversidge 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 946 KB

Therapeutic and diagnostic agents can be formulated into colloidal or particulate dispersions to enhance their utility and possibly to modify their pharmacodynamics. Since certain of these agents are intended for intravenous administration, it is imperative that the cardiovascular safety profile be